Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
Annals of Surgical Oncology
|
October 5, 2011
Improving nodal harvest in colorectal cancer: so what?
Geoffrey A Porter, Robin Urquhart, Jingyu Bu, et al.
Clinical Breast Cancer
|
May 13, 2019
Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis
Gillian C Bethune, Manolhas A Karkada, Ryan DeCoste, et al.
Research and Theory for Nursing Practice
|
September 8, 2005
Gendered and cultured relations: exploring African Nova Scotians' perceptions and experiences of breast and prostate cancer
Joan Evans, Lorna Butler, Josephine Etowa, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Seronegative Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin
Geraint Berger, Caitlin Jackson-Tarlton, Daniel Rayson, et al.
Breast (Edinburgh, Scotland)
|
March 23, 2024
Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center
John Loggie, Penelope J Barnes, Michael D Carter, et al.
American Journal of Clinical Oncology
|
October 11, 2008
Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model
George Dranitsaris, Daniel Rayson, Mark Vincent, et al.
Breast Cancer Research and Treatment
|
November 6, 2007
The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines
George Dranitsaris, Daniel Rayson, Mark Vincent, et al.
Plos One
|
August 14, 2020
Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients
Arik Drucker, Evelyn M Teh, Ripsik Kostyleva, et al.
Breast Cancer Research and Treatment
|
February 3, 2007
Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray
Kelly Dakin Haché, Samantha Gray, Penny J Barnes, et al.
Neuroendocrinology
|
April 14, 2011
Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors
Thomas Arnason, Heidi L Sapp, Penelope J Barnes, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
Annals of Surgical Oncology
|
October 5, 2011
Improving nodal harvest in colorectal cancer: so what?
Geoffrey A Porter, Robin Urquhart, Jingyu Bu, et al.
Clinical Breast Cancer
|
May 13, 2019
Isolated Tumor Cells in Sentinel Lymph Nodes of Primary Invasive Breast Carcinoma: A Cohort Analysis
Gillian C Bethune, Manolhas A Karkada, Ryan DeCoste, et al.
Research and Theory for Nursing Practice
|
September 8, 2005
Gendered and cultured relations: exploring African Nova Scotians' perceptions and experiences of breast and prostate cancer
Joan Evans, Lorna Butler, Josephine Etowa, et al.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Seronegative Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin
Geraint Berger, Caitlin Jackson-Tarlton, Daniel Rayson, et al.
Breast (Edinburgh, Scotland)
|
March 23, 2024
Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center
John Loggie, Penelope J Barnes, Michael D Carter, et al.
American Journal of Clinical Oncology
|
October 11, 2008
Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model
George Dranitsaris, Daniel Rayson, Mark Vincent, et al.
Breast Cancer Research and Treatment
|
November 6, 2007
The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines
George Dranitsaris, Daniel Rayson, Mark Vincent, et al.
Plos One
|
August 14, 2020
Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients
Arik Drucker, Evelyn M Teh, Ripsik Kostyleva, et al.
Breast Cancer Research and Treatment
|
February 3, 2007
Clinical and pathological correlations in male breast cancer: intratumoral aromatase expression via tissue microarray
Kelly Dakin Haché, Samantha Gray, Penny J Barnes, et al.
Neuroendocrinology
|
April 14, 2011
Immunohistochemical expression and prognostic value of ER, PR and HER2/neu in pancreatic and small intestinal neuroendocrine tumors
Thomas Arnason, Heidi L Sapp, Penelope J Barnes, et al.
Page
of 9